TWD
BMRN icon

True Wealth Design’s BioMarin Pharmaceuticals BMRN Stock Holding History

True Wealth Design’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$57.4K Hold
957
– – 0.01% 458
2026
Q2 		$54.8K Sell
957
-695
-42% -$38.1K 0.01% 456
2026
Q1 		$93.3K Buy
1,652
+384
+30% +$22.4K 0.03% 230
2025
Q4 		$75.4K Sell
1,268
-717
-36% -$39K 0.02% 233
2025
Q3 		$108K Buy
1,985
+1,609
+428% +$92K 0.03% 148
2025
Q2 		$20.7K Sell
376
-969
-72% -$57.1K 0.01% 377
2025
Q1 		$95.1K Buy
1,345
+1,239
+1,169% +$83.4K 0.04% 101
2024
Q4 		$6.97K Sell
106
-704
-87% -$47.2K ﹤0.01% 474
2024
Q3 		$56.9K Buy
810
+804
+13,400% +$67.2K 0.02% 120
2024
Q2 		$494 Hold
6
– – ﹤0.01% 654
2024
Q1 		$525 Buy
6
+2
+50% +$179 ﹤0.01% 613
2023
Q4 		$386 Hold
4
– – ﹤0.01% 543
2023
Q3 		$354 Hold
4
– – ﹤0.01% 515
2023
Q2 		$347 Hold
4
– – ﹤0.01% 547
2023
Q1 		$389 Hold
4
– – ﹤0.01% 586
2022
Q4 		$414 Buy
+4
New +$376 ﹤0.01% 505

Other funds holding BMRN

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

True Wealth Design's BMRN Position: Q3 2026 in Review

True Wealth Design held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 957 shares worth $57.4K. The position accounts for 0.01% of the portfolio, ranked #458.

True Wealth Design first reported a position in BMRN in Q4 2022 and has held it in 16 quarters since. The position peaked at $108K in Q3 2025. 29 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • True Wealth Design held 957 shares of BioMarin Pharmaceuticals worth $57.4K as of Q3 2026.
  • True Wealth Design left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
  • BioMarin Pharmaceuticals made up 0.01% of True Wealth Design's portfolio in Q3 2026, its #458 holding.
  • True Wealth Design first reported a position in BioMarin Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • True Wealth Design's BioMarin Pharmaceuticals position peaked at $108K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.